Literature DB >> 28202881

The exercise paradox may be solved by measuring the overall thrombotic state using native blood.

Hideo Ikarugi1, Junichiro Yamamoto.   

Abstract

While exercise is widely believed to prevent atherothrombotic diseases, it occasionally causes sudden death. This exercise paradox may be due to the inadequate testing of the thrombotic and thrombolytic status. A recently developed shear-induced thrombosis/endogenous fibrinolysis test performed with non-anticoagulated blood samples allows the assessment of the thrombotic state of an individual both at rest and after exercise. This sensitive and physiologically relevant test may help to solve the aforementioned exercise paradox.

Entities:  

Mesh:

Year:  2017        PMID: 28202881     DOI: 10.5582/ddt.2016.01077

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN: 1881-7831


  4 in total

Review 1.  Effects of Catheterization on Artery Function and Health: When Should Patients Start Exercising Following Their Coronary Intervention?

Authors:  Andrea Tryfonos; Daniel J Green; Ellen A Dawson
Journal:  Sports Med       Date:  2019-03       Impact factor: 11.136

Review 2.  Prevention of thrombotic disorders by antithrombotic diet and exercise: evidence by using global thrombosis tests.

Authors:  Junichiro Yamamoto; Yoshinobu Ijiri; Hideo Ikarugi; Kazunori Otsui; Nobutaka Inoue; Kjell S Sakariassen
Journal:  Future Sci OA       Date:  2018-01-24

Review 3.  Global thrombosis test for assessing thrombotic status and efficacy of antithrombotic diet and other conditions.

Authors:  Masahiro Murakami; Kazunori Otsui; Yoshinobu Ijiri; Muneshige Shimizu; Hideo Ikarugi; Wataru Shioyama; Junichiro Yamamoto; Kjell S Sakariassen
Journal:  Future Sci OA       Date:  2022-01-31

4.  Effects of Four-Week Rehabilitation Program on Hemostasis Disorders in Patients with Spinal Cord Injury.

Authors:  Magdalena Mackiewicz-Milewska; Małgorzata Cisowska-Adamiak; Danuta Rość; Iwona Głowacka-Mrotek; Iwona Świątkiewicz
Journal:  J Clin Med       Date:  2020-06-12       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.